Volker Menschik

Volker Menschik currently serves as the Group Chief Operating Officer at Partex NV, a position held since March 2024. Prior to this role, Menschik was the Chief Operating Officer of Cureteq AG, a subsidiary of Partex, from January 2022 to March 2024. From October 2016 to January 2022, Menschik held the title of Chief Business Officer at CRS Clinical Research Services, focusing on business and corporate development. Earlier career experiences include roles at PAREXEL where Menschik advanced from Senior Project Manager to Corp. VP Global Head of Early Phase Operations, overseeing a team of over 900 employees across multiple locations. Additionally, Menschik worked at PAREXEL in various leadership positions within Early Phase operations in Europe and South Africa and began professional career as a Scientist at Boehringer Mannheim from December 1991 to February 1998.